-
Something wrong with this record ?
Randomized comparison of atrioventricular node re-entry tachycardia and atrial flutter catheter ablation with and without fluoroscopic guidance: ZeroFluoro study
F. Lehar, N. Szegedi, J. Hejc, J. Jez, F. Soucek, T. Kulik, A. Siruckova, Z. Sallo, KV. Nagy, B. Merkely, L. Geller, Z. Starek
Language English Country England, Great Britain
Document type Journal Article, Randomized Controlled Trial
NLK
Free Medical Journals
from 1999 to 1 year ago
PubMed Central
from 2008
Open Access Digital Library
from 1999-01-01
Medline Complete (EBSCOhost)
from 1999-01-01
Oxford Journals Open Access Collection
from 1999-01-01
- MeSH
- Tachycardia, Atrioventricular Nodal Reentry * diagnostic imaging surgery MeSH
- Fluoroscopy methods MeSH
- Atrial Flutter * diagnostic imaging surgery MeSH
- Catheter Ablation * adverse effects methods MeSH
- Middle Aged MeSH
- Humans MeSH
- Atrioventricular Node MeSH
- Prospective Studies MeSH
- Arrhythmias, Cardiac surgery MeSH
- Tachycardia, Supraventricular * diagnostic imaging surgery MeSH
- Treatment Outcome MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Publication type
- Journal Article MeSH
- Randomized Controlled Trial MeSH
AIMS: Interventional cardiology procedures may expose patients and staff to considerable radiation doses. We aimed to assess whether exposure to ionizing radiation during catheter ablation of supraventricular tachycardia (SVT) can be completely avoided. METHODS AND RESULTS: In this prospective randomized study, patients with SVT (atrioventricular re-entrant tachycardia n = 94, typical atrial flutter n = 29) were randomly assigned in a 1:1 ratio to catheter ablation with conventional fluoroscopic guidance (CF group) or with the EnSite Precision mapping system [zerofluoro (ZF) group]. Acute procedural parameters, increased stochastic risk of cancer incidence and 6-month follow-up data were assessed. Between May 2019 and August 2020, 123 patients were enrolled. Clinical parameters were comparable. Median procedural time was 60.0 and 58.0 min, median fluoroscopy time and estimated median effective dose were 240 s vs. 0 and 0.38 mSv vs. 0 and arrhythmia recurrence was 5% and 7.9% in the CF and ZF groups, respectively. The acute success rate was 98.4% in both groups. No procedure-related complications were reported. At an average age of 55.5 years and median radiation exposure of 0.38 mSv, the estimate of increased incidence was approximately 1 in 14 084. The estimated mortality rate was 1 per 17 857 exposed persons. CONCLUSIONS: The procedural safety and efficacy of the zero-fluoroscopic approach are similar to those of conventional fluoroscopy-based ablation for atrioventricular nodal re-entrant tachycardia and atrial flutter. Under the assumption of low radiation dose, the excessive lifetime risk of malignancy in the CF group due to electrophysiology procedure is reasonably small, whilst totally reduced in zero fluoroscopy procedures.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22033078
- 003
- CZ-PrNML
- 005
- 20230131151136.0
- 007
- ta
- 008
- 230120s2022 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1093/europace/euac049 $2 doi
- 035 __
- $a (PubMed)35979596
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Lehar, Frantisek $u International Clinical Research Center, Interventional Cardiac Electrophysiology Group, St. Anne's University Hospital Brno, Pekařská 53, 656 91 Brno, Czech Republic $u First Department of Internal Medicine/Cardioangiology, St. Anne's Hospital, Masaryk University, Pekařská 53, 656 91 Brno, Czech Republic
- 245 10
- $a Randomized comparison of atrioventricular node re-entry tachycardia and atrial flutter catheter ablation with and without fluoroscopic guidance: ZeroFluoro study / $c F. Lehar, N. Szegedi, J. Hejc, J. Jez, F. Soucek, T. Kulik, A. Siruckova, Z. Sallo, KV. Nagy, B. Merkely, L. Geller, Z. Starek
- 520 9_
- $a AIMS: Interventional cardiology procedures may expose patients and staff to considerable radiation doses. We aimed to assess whether exposure to ionizing radiation during catheter ablation of supraventricular tachycardia (SVT) can be completely avoided. METHODS AND RESULTS: In this prospective randomized study, patients with SVT (atrioventricular re-entrant tachycardia n = 94, typical atrial flutter n = 29) were randomly assigned in a 1:1 ratio to catheter ablation with conventional fluoroscopic guidance (CF group) or with the EnSite Precision mapping system [zerofluoro (ZF) group]. Acute procedural parameters, increased stochastic risk of cancer incidence and 6-month follow-up data were assessed. Between May 2019 and August 2020, 123 patients were enrolled. Clinical parameters were comparable. Median procedural time was 60.0 and 58.0 min, median fluoroscopy time and estimated median effective dose were 240 s vs. 0 and 0.38 mSv vs. 0 and arrhythmia recurrence was 5% and 7.9% in the CF and ZF groups, respectively. The acute success rate was 98.4% in both groups. No procedure-related complications were reported. At an average age of 55.5 years and median radiation exposure of 0.38 mSv, the estimate of increased incidence was approximately 1 in 14 084. The estimated mortality rate was 1 per 17 857 exposed persons. CONCLUSIONS: The procedural safety and efficacy of the zero-fluoroscopic approach are similar to those of conventional fluoroscopy-based ablation for atrioventricular nodal re-entrant tachycardia and atrial flutter. Under the assumption of low radiation dose, the excessive lifetime risk of malignancy in the CF group due to electrophysiology procedure is reasonably small, whilst totally reduced in zero fluoroscopy procedures.
- 650 _2
- $a srdeční arytmie $x chirurgie $7 D001145
- 650 12
- $a flutter síní $x diagnostické zobrazování $x chirurgie $7 D001282
- 650 _2
- $a nodus atrioventricularis $7 D001283
- 650 12
- $a katetrizační ablace $x škodlivé účinky $x metody $7 D017115
- 650 _2
- $a fluoroskopie $x metody $7 D005471
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a prospektivní studie $7 D011446
- 650 12
- $a atrioventrikulární nodální reentry tachykardie $x diagnostické zobrazování $x chirurgie $7 D013611
- 650 12
- $a supraventrikulární tachykardie $x diagnostické zobrazování $x chirurgie $7 D013617
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a randomizované kontrolované studie $7 D016449
- 700 1_
- $a Szegedi, Nándor $u Heart and Vascular Center, Semmelweis University, Városmajor str. 68, 1122 Budapest, Hungary
- 700 1_
- $a Hejc, Jakub $u International Clinical Research Center, Interventional Cardiac Electrophysiology Group, St. Anne's University Hospital Brno, Pekařská 53, 656 91 Brno, Czech Republic
- 700 1_
- $a Jez, Jiri $u International Clinical Research Center, Interventional Cardiac Electrophysiology Group, St. Anne's University Hospital Brno, Pekařská 53, 656 91 Brno, Czech Republic $u First Department of Internal Medicine/Cardioangiology, St. Anne's Hospital, Masaryk University, Pekařská 53, 656 91 Brno, Czech Republic
- 700 1_
- $a Soucek, Filip $u International Clinical Research Center, Interventional Cardiac Electrophysiology Group, St. Anne's University Hospital Brno, Pekařská 53, 656 91 Brno, Czech Republic $u First Department of Internal Medicine/Cardioangiology, St. Anne's Hospital, Masaryk University, Pekařská 53, 656 91 Brno, Czech Republic
- 700 1_
- $a Kulik, Tomas $u International Clinical Research Center, Interventional Cardiac Electrophysiology Group, St. Anne's University Hospital Brno, Pekařská 53, 656 91 Brno, Czech Republic $u First Department of Internal Medicine/Cardioangiology, St. Anne's Hospital, Masaryk University, Pekařská 53, 656 91 Brno, Czech Republic
- 700 1_
- $a Siruckova, Anna $u International Clinical Research Center, Interventional Cardiac Electrophysiology Group, St. Anne's University Hospital Brno, Pekařská 53, 656 91 Brno, Czech Republic $u First Department of Internal Medicine/Cardioangiology, St. Anne's Hospital, Masaryk University, Pekařská 53, 656 91 Brno, Czech Republic
- 700 1_
- $a Sallo, Zoltan $u Heart and Vascular Center, Semmelweis University, Városmajor str. 68, 1122 Budapest, Hungary
- 700 1_
- $a Nagy, Klaudia Vivien $u Heart and Vascular Center, Semmelweis University, Városmajor str. 68, 1122 Budapest, Hungary
- 700 1_
- $a Merkely, Bela $u Heart and Vascular Center, Semmelweis University, Városmajor str. 68, 1122 Budapest, Hungary $1 https://orcid.org/0000000165140723
- 700 1_
- $a Geller, László $u Heart and Vascular Center, Semmelweis University, Városmajor str. 68, 1122 Budapest, Hungary
- 700 1_
- $a Starek, Zdeněk $u International Clinical Research Center, Interventional Cardiac Electrophysiology Group, St. Anne's University Hospital Brno, Pekařská 53, 656 91 Brno, Czech Republic $u First Department of Internal Medicine/Cardioangiology, St. Anne's Hospital, Masaryk University, Pekařská 53, 656 91 Brno, Czech Republic $1 https://orcid.org/0000000295101386
- 773 0_
- $w MED00149837 $t Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology $x 1532-2092 $g Roč. 24, č. 10 (2022), s. 1636-1644
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35979596 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230120 $b ABA008
- 991 __
- $a 20230131151132 $b ABA008
- 999 __
- $a ok $b bmc $g 1891692 $s 1184413
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2022 $b 24 $c 10 $d 1636-1644 $e 2022Oct13 $i 1532-2092 $m Europace $n Europace $x MED00149837
- LZP __
- $a Pubmed-20230120